The long term goals of our research laboratory are to develop therapies for age related macular degeneration (AMD) and retinitis pigmentosa (RP).  In addition, we have a significant interest in the development of viral and non-viral gene transfer technologies.

Download Review Article (PDF):  Kumar-Singh, R.  Barriers for Retinal Gene Therapy: Separating Fact from Fiction.  Vision Research, 48; 16: 1671-1680, 2008.